Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Curaleaf Holdings, Inc.
  6. News
  7. Summary
    CURA   CA23126M1023

CURALEAF HOLDINGS, INC.

(CURA)
  Report
Delayed Quote. Delayed CANADIAN NATIONAL STOCK EXCHANGE - 10/15 03:59:58 pm
13.1 CAD   -1.95%
10/13Curaleaf Holdings, Inc. Offers New Select Snooze Bites
CI
10/12CURALEAF : Completes Acquisition of Los Sueños - Form 6-K
PU
10/05CURALEAF : Completes acquisition of los suenos
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Curaleaf Is Ready To Serve New Jersey's Growing Market With New Bordentown Location

08/25/2021 | 08:00am EDT

Curaleaf Holdings, Inc. announced the opening of Curaleaf Bordentown, the company's 109th dispensary nationwide. The Company also announced the launch of its Select brand in New Jersey, expanding the brand's reach to 19 states. Select Bites, which feature the brand's award-winning, concentrated broad-spectrum oil and science-based formulations that offer precise, consistent cannabis experiences for any occasion, are now available at all Curaleaf New Jersey locations. Curaleaf Bordentown is a 9,546 square foot dispensary located at 191 Route 130, and is the second location that Curaleaf has opened in the state this year. All three of Curaleaf'sNew Jersey dispensaries are strategically positioned near the New York and Pennsylvania borders, allowing the Company to better serve the growing East Coast adult-use market. In June, Curaleaf started serving patients at Curaleaf Edgewater Park and announced that it had tripled its cultivation capabilities with its new facility in Winslow Township. Curaleaf's strategic expansion in New Jersey will allow the Company to serve both the existing medical market and the forthcoming adult-use market, which could launch as early as the end of this year. Through these latest expansion plans, Curaleaf expects to add over 200 new jobs to the local economy. Select Classic Bites are available in three flavors including Passion Fruit, Strawberry Peach and Blueberry. Later this year, Select Nano Bites and Select Squeeze will be introduced to the New Jersey market.


ę S&P Capital IQ 2021
All news about CURALEAF HOLDINGS, INC.
10/13Curaleaf Holdings, Inc. Offers New Select Snooze Bites
CI
10/12CURALEAF : Completes Acquisition of Los Sueños - Form 6-K
PU
10/05CURALEAF : Completes acquisition of los suenos
AQ
10/04Curaleaf Holdings, Inc. completed the acquisition of Los Sueños Farms LLC.
CI
09/27CURALEAF : Select Introduces Breakthrough Vape Technology with Cliq by Select (Form 6-K)
PU
09/23CURALEAF : New High-Tech Hardware System to Launch in 16 States by Year End
AQ
09/23STOXX EUROPE 600 : Russia's Renaissance Insurance Said to Seek $250 Million in IPO
MT
09/22Curaleaf Holdings, Inc. Announces the Release of Cliq by Select
CI
09/14CURALEAF : QUARTERLY LISTING STATEMENT (Form 6-K)
PU
09/09CURALEAF : Announces Voting Results of its Annual and Special Meeting of Shareholders
AQ
More news
Analyst Recommendations on CURALEAF HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 1 287 M - -
Net income 2021 6,03 M - -
Net cash 2021 87,2 M - -
P/E ratio 2021 -1 816x
Yield 2021 -
Capitalization 7 487 M 7 490 M -
EV / Sales 2021 5,75x
EV / Sales 2022 3,97x
Nbr of Employees -
Free-Float 57,8%
Chart CURALEAF HOLDINGS, INC.
Duration : Period :
Curaleaf Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CURALEAF HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 10,58 $
Average target price 21,35 $
Spread / Average Target 102%
EPS Revisions
Managers and Directors
Joseph D. Bayern President & Chief Executive Officer
Anuranjan Krishnan Kalia Chief Financial Officer
Boris A. Jordan Executive Chairman
Robert Winnicki Senior VP-Research & Product Development
Neil P. Davidson Chief Operating Officer
Sector and Competitors